There was a problem introduced in version 1.6 that prevented users from creating Adverse Event, Amendments, or Continuing Reviews on converted studies. Additionally, for new (non-converted) studies, users were prevented from created Adverse Events, Amendments, and Continuing Reviews on the same day that the study was approved. This problem has been corrected.